References
- 1. JALAN R, FERNANDEZ J, WIEST R, SCHNABL B, MOREAU R, ANGELI P, et al. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013. Journal of Hepatology 2014;60(6):1310–1324.
- 2. PIANO S, SINGH V, CARACENI P, MSIWALL R, ALESSANDRIA C, FERNANFEZ J, et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 2019;156: 1368–1380.
- 3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
- 4. MARCIANO S, DIAZ JM, DIRCHWOLF M, GADANO A. Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies. Hepat Med. 2019;11:13–22.
- 5. GAETANO JN, MICIC D, ARONSOHN A, REDDY G, TE H, REAU NS, et al. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016;31:1025–1030.
- 6. KIM JJ, TSUKAMOTO MM, MATHUR AK, GHOMRI YM, HOU LA, SHEIBANI S, et al Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109:1436–1442.
- 7. MACINTOSH T. Emergency Management of Spontaneous Bacterial Peritonitis – A Clinical Review. Cureus 2018;10(3):e2253.
- 8. MERCALDI CJ, LANES SF. Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis.Chest. 2013;143:532–538.
- 9. CHINNOCK B, AFARIAN H, MINNIGAN H, BUTLER J, HENDEY GW. Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis.Ann Emerg Med. 2008;52:268–273.
- 10. DEVER JB, SHEIKH MY. Review article: spontaneous bacterial peritonitis – bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther.2015; 41:1116-1131.
- 11. VAN DE GEIJN GM, VAN GENT M, VAN PUL-BOM N, BEUNIS MH, VAN TILBURG AJ, NJO TL. A new flow cytometric method for differential cell counting in ascitic fluid. Cytometry B Clin Cytom 2016;90:506–511.
- 12. SORIANO G, CASTELLOTE J, ALVAREZ C, GIRBAU A, GORDILLO J, BALIELLAS C, et al. Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management. J Hepatol. 2010;52:39–44.
- 13. RUNYON BA. American Association for the Study of Liver Diseases (AASLD) Practice Guidelines Committee. Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012.
- 14. SHIZUMA T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World J Hepatol. 2018;10(2):254-266.
- 15. VERMA R, SATAPATHY SK, BILAL M. Procalcitonin and C-reactive protein in the diagnosis of spontaneous bacterial peritonitis. Transl Gastroenterol Hepatol 2020.
- 16. YANG Y, Li L, QU C, ZENG B, LIANG S, LUO Z, et al. Diagnostic Accuracy of Serum Procalcitonin for Spontaneous Bacterial Peritonitis Due to End-stage Liver Disease: A Meta-analysis. Medicine (Baltimore). 2015;94(49):e2077.
- 17. LESINKA M, HARTLEB M, GUTKOWSKI K, NOWAKOWSKA-DULAWA E. Procalcitonin and macrophage inflammatory protein-1 beta (MIP-1 beta) in serum and peritoneal fluid of patients with decompensated cirrhosis and spontaneous bacterial peritonitis. Adv Med Sci. 2014;59:52–56.
- 18. GULER K, VATANSEVER S, KAYACAN SM, SALMAYENLI N, AKKAYA V, ERK O, et al. High sensitivity C-reactive protein in spontaneous bacterial peritonitis with nonneutrocytic ascites. Hepatogastroenterology. 2009;56(90):452–5.
- 19. KADAM N, ACHARYA S, SHUKLA S, GUPTA K. Ascitic Fluid High Sensitive C-Reactive Protein (hs-CRP). A Prognostic Marker in Cirrhosis with Spontaneous Bacterial Peritonitis. J Clin Diagn Res. 2016;10(4):OC20–4.
- 20. SHIZUMA T. Diagnostic Laboratory Markers for Spontaneous Bacterial Peritonitis. Ann Clin Lab Res. 2016; 4:4.
- 21. LEE SS, MIN HJ, CHOI JY, CHO HC, KIM JJ, LEE JM, et al. Usefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosis. BMC Gastroenterol. 2016;16(1):132.
- 22. FERNANDES SR, SANTOS P, FATELA N, BALDAIA C, TATO MARINHO R, PROENCA H, et al. Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial Peritonitis. J Clin Lab Anal. 2016;30(6):1139–1145.
- 23. DIBAS M, RAJAB AM, ZAGHLOUL MS, ATIAH MJ, ALJUNDI S, AMIR A, et al. Ascitic calprotectin for the diagnosis of spontaneous bacterial peritonitis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020;32(9):1075–1083.
- 24. KOULAOUZIDIS A. Diagnosis of spontaneous bacterial peritonitis: an update on leucocyte esterase reagent strips. World J Gastroenterol. 2011;17(9):1091–4.
- 25. KOULAOUZIDIS A, LEONTIADIS GI, ABDULLAH M, MOSCHOS J, GASEM J, THARAKAN J, et al. Leucocyte esterase reagent strips for the diagnosis of spontaneous bacterial peritonitis: a systematic review. Eur J Gastroenterol Hepatol. 2008;20:1055–1060.
- 26. ABDEL-RAZIK A, MOUSA N, ELBAZ S, EISSA M, ELHELALY R, ELDARS W. Diagnostic utility of interferon gamma-induced protein 10 kDa in spontaneous bacterial peritonitis: single-center study. Eur J Gastroenterol Hepatol. 2015;27:1087–1093.
- 27. ICHOU L, CARBONELL N, RAUTOU PE, LAURANS L, BOURCIER S, PICHEREAU C, et al. Ascitic fluid TREM-1 for the diagnosis of spontaneous bacterial peritonitis. Gut. 2016;65:536–538.
- 28. 28. KIM JK, CHON CY, KIM JH, KIM YJ, CHO JH, BANG SM, et al. Changes in serum and ascitic monocyte chemotactic protein-1 (MCP-1) and IL-10 levels in cirrhotic patients with spontaneous bacterial peritonitis. J Interferon Cytokine Res. 2007;27:227–230.
- 29. EL-TOUKHY N, EMAM SM. Diagnostic and Prognostic Values of Monocyte Chemotactic Protein-1 in Ascitic Fluid of Patients with Spontaneous Bacterial Peritonitis. Egypt J Immunol. 2016;23:17–27.
- 30. AGIASOTELLI D, ALEXOPOULOU A, VASILIEVA L, HADZIYANNIS E, GOUKOUS D, DAIKOS GL, et al. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis. Liver Int. 2017;37:576–582.
- 31. CULLARO G, KIM G, PEREIRA MR, BROWN RS Jr, VERNA EC. Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis. Dig Dis Sci. 2017;62:3487–3494.
- 32. ABDEL-RAZIK A, ELDARS W, ELHELALY R, ELDEEB AA, ABDELSALAM M, EL-WAK N, et al. Homocysteine: a new diagnostic marker in spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol. 2018;30(7):779–785.
- 33. BADAWI R, ASGHAR MN, ABD-ELSALAM S, ELSHWEIKH SA, HAYDARA T, Alnabawy SM, et al. Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis. Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):140–148.
- 34. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3): 397–417.
- 35. MERLI M, LUCIDI C. Bacterial resistance in cirrhotic patients: An emerging reality. Journal of Hepatology. 2012; 56(4): 756–757.
- 36. FRIEDMAN ND, KAYE KS, STOUT JE, MCGARRY SA, TRIVETTE SL, BRIGGS JP, et al. Health care associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791–797.
- 37. SORT P, NAVASA M, ARROYO V, ALDEGUER X, PLANAS R, RUIZ-DEL-ARBOL L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–409.
- 38. GARCIA-MARTINEZ R, CARACENI P, BERNARDI M, GINES P, ARROYO V, JALAN R. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013;58:1836–1846.